David Rouquié
David Rouquié has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
F. Schorsch
Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France
2 shared publicationsH. Tinwell
Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France
2 shared publications- Joerg Wichard
Department of Genetic Toxicology Bayer AG 13353 Berlin Germany
2 shared publications - Oscar Méndez-Lucio
Recursion (United States)
2 shared publications R. Bars
Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France
2 shared publicationsA. Sarrabay
INSERM, Université Paris-Sud, Faculté de Pharmacie, Châtenay-Malabry, France; UniverSud, INSERM, UMR-996 "Inflammation, Chemokines and Immunopathology", Châtenay-Malabry, France; Bayer SAS, 16, rue Jean Marie Leclair, 69009 Lyon, France
1 shared publication
Latest Publications
- Open Access
Cell Painting and chemical structure read-across can complement each other for rat acute oral toxicity prediction in chemical early de-risking
Small molecule discovery entails the identifying and developing of chemical compounds with optimized safety properties in different target species including laboratory animals, human and environmental species. Early de-risking supports the identification of candidates with improved safety profiles in the development of new chemical compounds. In vivo studies are performed in the early assessment of acute oral toxicity, an important endpoint in the development of crop protection products. Because in vivo studies are long, costly, and raise ethical concerns, non-animal alternatives are needed. Several models were analyzed to classify compounds as highly acutely toxic (LD50 ≤ 60 mg/kg) or not. First, the publicly available QSAR model, CATMoS, was used to classify 630 Bayer Crop Science compounds. This model did not show good results (balanced accuracy of 0.52) as the compounds were in gaps of the model applicability domain. Interestingly, training a K nearest neighbor’s model (equivalent to read-across) using specifically the compound structure information, good classifications were obtained (balanced accuracy of 0.81). Then, this study explored whether morphological profiles obtained using Cell Painting in vitro assay on U2OS cells could assist in the prediction of rat acute oral toxicity and how those predictions could complement those made by QSAR models using chemical structures. Compounds with known acute oral toxicity were selected and a Cell Painting campaign were conducted on 226 compounds at 10 µM, 31.6 µM, and 100 µM. Binary classifiers based on K nearest neighbors, were developed to categorize compounds as highly acutely toxic (LD50 ≤ 60 mg/kg) or not. These classifiers were built, either using the compound chemical structure information (Morgan Fingerprint) or morphological profiles obtained from Cell Painting. Our results showed that the classification of compounds, using a read-across approach, as very acutely oral toxic or not, was possible using chemical structure information, U2OS cell morphological profiles or the combination of both. When classifying compounds structurally similar to those used to train the classifier, the chemical structure information was more predictive (mean balanced accuracy of 0.82). Conversely, when compounds to classify were structurally different from compounds used to train the classifier, the U2OS cell morphological profiles were more predictive (mean balanced accuracy of 0.72). The combination of both models allowed, when classifying compounds structurally similar to those used to train the classifiers, to slightly enhance the predictions (mean balanced accuracy of 0.85).
Open AccessCell Painting and chemical structure read-across can complement each other for rat acute oral toxicity prediction in chemical early de-risking
Small molecule discovery entails the identifying and developing of chemical compounds with optimized safety properties in different target species including laboratory animals, human and environmental species. Early de-risking supports the identification of candidates with improved safety profiles in the development of new chemical compounds. In vivo studies are performed in the early assessment of acute oral toxicity, an important endpoint in the development of crop protection products. Because in vivo studies are long, costly, and raise ethical concerns, non-animal alternatives are needed. Several models were analyzed to classify compounds as highly acutely toxic (LD50 ≤ 60 mg/kg) or not. First, the publicly available QSAR model, CATMoS, was used to classify 630 Bayer Crop Science compounds. This model did not show good results (balanced accuracy of 0.52) as the compounds were in gaps of the model applicability domain. Interestingly, training a K nearest neighbor’s model (equivalent to read-across) using specifically the compound structure information, good classifications were obtained (balanced accuracy of 0.81). Then, this study explored whether morphological profiles obtained using Cell Painting in vitro assay on U2OS cells could assist in the prediction of rat acute oral toxicity and how those predictions could complement those made by QSAR models using chemical structures. Compounds with known acute oral toxicity were selected and a Cell Painting campaign were conducted on 226 compounds at 10 µM, 31.6 µM, and 100 µM. Binary classifiers based on K nearest neighbors, were developed to categorize compounds as highly acutely toxic (LD50 ≤ 60 mg/kg) or not. These classifiers were built, either using the compound chemical structure information (Morgan Fingerprint) or morphological profiles obtained from Cell Painting. Our results showed that the classification of compounds, using a read-across approach, as very acutely oral toxic or not, was possible using chemical structure information, U2OS cell morphological profiles or the combination of both. When classifying compounds structurally similar to those used to train the classifier, the chemical structure information was more predictive (mean balanced accuracy of 0.82). Conversely, when compounds to classify were structurally different from compounds used to train the classifier, the U2OS cell morphological profiles were more predictive (mean balanced accuracy of 0.72). The combination of both models allowed, when classifying compounds structurally similar to those used to train the classifiers, to slightly enhance the predictions (mean balanced accuracy of 0.85).
- Open Access
- 23 April 2020
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 8, 296
Exploring the Use of Compound-Induced Transcriptomic Data Generated From Cell Lines to Predict Compound Activity Toward Molecular Targets
Pharmaceutical or phytopharmaceutical molecules rely on the interaction with one or more specific molecular targets to induce their anticipated biological responses. Nonetheless, these compounds are also prone to interact with many other non-intended biological targets, also known as off-targets. Unfortunately, off-target identification is difficult and expensive. Consequently, QSAR models predicting the activity on a target have gained importance in drug discovery or in the de-risking of chemicals. However, a restricted number of targets are well characterized and hold enough data to build such in silico models. A good alternative to individual target evaluations is to use integrative evaluations such as transcriptomics obtained from compound-induced gene expression measurements derived from cell cultures. The advantage of these particular experiments is to capture the consequences of the interaction of compounds on many possible molecular targets and biological pathways, without having any constraints concerning the chemical space. In this work, we assessed the value of a large public dataset of compound-induced transcriptomic data, to predict compound activity on a selection of 69 molecular targets. We compared such descriptors with other QSAR descriptors, namely the Morgan fingerprints (similar to extended-connectivity fingerprints). Depending on the target, active compounds could show similar signatures in one or multiple cell lines, whether these active compounds shared similar or different chemical structures. Random forest models using gene expression signatures were able to perform similarly or better than counterpart models built with Morgan fingerprints for 25% of the target prediction tasks. These performances occurred mostly using signatures produced in cell lines showing similar signatures for active compounds toward the considered target. We show that compound-induced transcriptomic data could represent a great opportunity for target prediction, allowing to overcome the chemical space limitation of QSAR models.
- 23 April 2020
- Published by Frontiers Media SA in Frontiers in Chemistry
- Vol. 8, 296
Open AccessExploring the Use of Compound-Induced Transcriptomic Data Generated From Cell Lines to Predict Compound Activity Toward Molecular Targets
Pharmaceutical or phytopharmaceutical molecules rely on the interaction with one or more specific molecular targets to induce their anticipated biological responses. Nonetheless, these compounds are also prone to interact with many other non-intended biological targets, also known as off-targets. Unfortunately, off-target identification is difficult and expensive. Consequently, QSAR models predicting the activity on a target have gained importance in drug discovery or in the de-risking of chemicals. However, a restricted number of targets are well characterized and hold enough data to build such in silico models. A good alternative to individual target evaluations is to use integrative evaluations such as transcriptomics obtained from compound-induced gene expression measurements derived from cell cultures. The advantage of these particular experiments is to capture the consequences of the interaction of compounds on many possible molecular targets and biological pathways, without having any constraints concerning the chemical space. In this work, we assessed the value of a large public dataset of compound-induced transcriptomic data, to predict compound activity on a selection of 69 molecular targets. We compared such descriptors with other QSAR descriptors, namely the Morgan fingerprints (similar to extended-connectivity fingerprints). Depending on the target, active compounds could show similar signatures in one or multiple cell lines, whether these active compounds shared similar or different chemical structures. Random forest models using gene expression signatures were able to perform similarly or better than counterpart models built with Morgan fingerprints for 25% of the target prediction tasks. These performances occurred mostly using signatures produced in cell lines showing similar signatures for active compounds toward the considered target. We show that compound-induced transcriptomic data could represent a great opportunity for target prediction, allowing to overcome the chemical space limitation of QSAR models.
- Open Access
- 17 January 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Cell Morphology-Guided De Novo Hit Design by Conditioning Generative Adversarial Networks on Phenotypic Image Features
Developing new small molecules that are bioactive is time-consuming, costly and rarely successful. As a mitigation strategy, we apply, for the first time, generative adversarial networks to de novo design of small molecules using a phenotype-based drug discovery approach. We trained our model on a set of 30,000 compounds and their respective morphological profiles extracted from high content images; no target information was used to train the model. Using this approach, we were able to automatically design agonist-like compounds of different molecular targets.
- 17 January 2020
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessCell Morphology-Guided De Novo Hit Design by Conditioning Generative Adversarial Networks on Phenotypic Image Features
Developing new small molecules that are bioactive is time-consuming, costly and rarely successful. As a mitigation strategy, we apply, for the first time, generative adversarial networks to de novo design of small molecules using a phenotype-based drug discovery approach. We trained our model on a set of 30,000 compounds and their respective morphological profiles extracted from high content images; no target information was used to train the model. Using this approach, we were able to automatically design agonist-like compounds of different molecular targets.
- Top Cited PapersOpen Access
- 3 January 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
De novo generation of hit-like molecules from gene expression signatures using artificial intelligence
Finding new molecules with a desired biological activity is an extremely difficult task. In this context, artificial intelligence and generative models have been used for molecular de novo design and compound optimization. Herein, we report a generative model that bridges systems biology and molecular design, conditioning a generative adversarial network with transcriptomic data. By doing so, we can automatically design molecules that have a high probability to induce a desired transcriptomic profile. As long as the gene expression signature of the desired state is provided, this model is able to design active-like molecules for desired targets without any previous target annotation of the training compounds. Molecules designed by this model are more similar to active compounds than the ones identified by similarity of gene expression signatures. Overall, this method represents an alternative approach to bridge chemistry and biology in the long and difficult road of drug discovery.
- 3 January 2020
- Published by Springer Nature in Nature Communications
- Vol. 11 (1) , 1-10
Top Cited PapersOpen AccessDe novo generation of hit-like molecules from gene expression signatures using artificial intelligence
Finding new molecules with a desired biological activity is an extremely difficult task. In this context, artificial intelligence and generative models have been used for molecular de novo design and compound optimization. Herein, we report a generative model that bridges systems biology and molecular design, conditioning a generative adversarial network with transcriptomic data. By doing so, we can automatically design molecules that have a high probability to induce a desired transcriptomic profile. As long as the gene expression signature of the desired state is provided, this model is able to design active-like molecules for desired targets without any previous target annotation of the training compounds. Molecules designed by this model are more similar to active compounds than the ones identified by similarity of gene expression signatures. Overall, this method represents an alternative approach to bridge chemistry and biology in the long and difficult road of drug discovery.
- 1 December 2015
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 289 (3) , 515-524
Low dose evaluation of the antiandrogen flutamide following a Mode of Action approach
- 1 December 2015
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 289 (3) , 515-524
Low dose evaluation of the antiandrogen flutamide following a Mode of Action approach
- 1 December 2014
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 70 (3) , 673-680
Thyroid tumor formation in the male mouse induced by fluopyram is mediated by activation of hepatic CAR/PXR nuclear receptors
- 1 December 2014
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 70 (3) , 673-680
Thyroid tumor formation in the male mouse induced by fluopyram is mediated by activation of hepatic CAR/PXR nuclear receptors
- 1 December 2010
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 58 (3) , S47-S53
Investigation of endogenous soybean food allergens by using a 2-dimensional gel electrophoresis approach
- 1 December 2010
- Published by Elsevier in Regulatory Toxicology and Pharmacology
- Vol. 58 (3) , S47-S53
Investigation of endogenous soybean food allergens by using a 2-dimensional gel electrophoresis approach